Travill Danielle I, Machalek Dorothy A, Rees Helen, Mbulawa Zizipho, Chikandiwa Admire, Munthali Richard, Petoumenos Kathy, Kaldor John M, Delany-Moretlwe Sinead
Wits RHI, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Kirby Institute, University of New South Wales-Kensington Campus, Sydney, New South Wales, Australia; Centre for Women's Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia.
Vaccine. 2024 Dec 2;42(26):126442. doi: 10.1016/j.vaccine.2024.126442. Epub 2024 Oct 18.
In 2014, South Africa implemented a national two-dose HPV vaccination programme using the bivalent vaccine for girls aged 9 years and older attending Grade 4 at public schools. We assessed HPV prevalence and risk factors among South African adolescent girls and young women (AGYW) aged 17-18 years who were ineligible for vaccination.
From June to December 2019, we surveyed AGYW aged 17-18 years attending primary care clinics in four South African provinces. Consenting participants completed a questionnaire, underwent HIV counselling and testing, and self-collected a vaginal swab for HPV testing. Samples were tested by Seegene AnyPlex™ II HPV28. We used summary statistics to describe the population characteristics and logistic regression to examine the association between risk factors and high-risk HPV detection.
910 participants were screened, 900 enrolled, 896 had valid HPV results, and 819 were unvaccinated and included in this study. Of these, 248 (30.3 %) were living with HIV and 597 (72.9 %) reported ever having vaginal sex. Overall, 463 (56.5 %) had at least one high-risk HPV detected, and 177 (21.6 %) had HPV16/18 detected. AGYW living with HIV had a higher prevalence of any high-risk HPV (65.3 % vs 52.7 %, p < 0.001) and HPV 16/18 (29.4 % vs 18.2 %, p < 0.001) compared to those without HIV. Multiple infections were also more common in participants living with HIV, with three or more high-risk HPV types detected in 32.3 % compared with 15.4 % of those without HIV (p < 0.001). In multivariate analyses, HIV status (p < 0.001) and higher number of lifetime sexual partners (p-trend<0.001) were associated with high-risk HPV detection.
High-risk HPV was very common in unvaccinated South Africa AGYW, especially among those living with HIV, highlighting the importance of HPV vaccination in settings with high HIV prevalence.
2014年,南非实施了一项全国性的两剂次人乳头瘤病毒(HPV)疫苗接种计划,对公立学校四年级及以上9岁及以上的女孩使用二价疫苗。我们评估了南非17至18岁不符合疫苗接种条件的青春期女孩和年轻女性(AGYW)中的HPV流行情况及风险因素。
2019年6月至12月,我们对南非四个省份初级保健诊所中17至18岁的AGYW进行了调查。同意参与的参与者完成了一份问卷,接受了HIV咨询和检测,并自行采集了阴道拭子进行HPV检测。样本通过Seegene AnyPlex™ II HPV28进行检测。我们使用汇总统计数据来描述人群特征,并使用逻辑回归分析来研究风险因素与高危HPV检测之间的关联。
共筛查了910名参与者,900名登记入组,896名获得了有效的HPV检测结果,819名未接种疫苗并纳入本研究。其中,248名(30.3%)感染了HIV,597名(72.9%)报告曾有过阴道性行为。总体而言,463名(56.5%)至少检测到一种高危HPV,177名(21.6%)检测到HPV16/18。与未感染HIV的AGYW相比,感染HIV的AGYW中任何高危HPV的患病率更高(65.3%对52.7%,p<0.001),HPV 16/18的患病率也更高(29.4%对18.2%,p<0.001)。多重感染在感染HIV的参与者中也更常见,32.3%的参与者检测到三种或更多高危HPV类型,而未感染HIV的参与者中这一比例为15.4%(p<0.001)。在多变量分析中,HIV感染状况(p<0.001)和终身性伴侣数量增加(p趋势<0.001)与高危HPV检测相关。
高危HPV在未接种疫苗的南非AGYW中非常普遍,尤其是在感染HIV的人群中,这凸显了在HIV高流行地区进行HPV疫苗接种的重要性。